When the biosimilar regulatory framework was first introduced in the European Union (EU) in 2004, the whole thing was a "new mess," says Finnish Medicines Agency senior researcher Niklas Ekman.
"Industry didn't know how to do things," Ekman said June 26 at the 2017 Parental Drug Association/US FDA Biosimilars Conference....






